Welcome to Arkansas State University!
+ Campus notification: Lockdown Lifted

The campus lockdown has been lifted.

(1:49 p.m.) There has been a report of two males with weapons near the Student Union. Lockdown immediately until further notice.

Update (2:15 p.m.): Three males, all wearing black, were last seen walking north near Dean St.

Update (2:31 p.m.): University Police, as well as other law enforcement from the area, are clearing campus buildings in the affected area. Please remain indoors until an all clear has been given.

Update (2:42 p.m.): The campus lockdown has been lifted.  A-State will resume normal operations.

Police are continuing to investigate the earlier report and are reviewing campus security footage.

More Information
University Communications

Emergency Contact
University Police

Social Media
Facebook Twitter
X Close

Lipscomb Distinguished Professor


  • Ph.D., Washington University in St. Louis (Plant Biology)
  • M.S., Oklahoma State University (Botany)
  • B.A., University of Oklahoma (Sociology)

Teaching Specialties

  • Plant Biotechnology
  • Cell Biology
  • Technology Entrepreneurship

Research Interests

  • Renewable resources—particularly biomass to ethanol
  • Foreign gene expression in transgenic plants
  • Plant cell wall structure and function
  • Plant cell biology and protein targeting


  • American Society of Plant Biologists
  • Specialty Crop Regulatory Assistance program executive steering committee
  • Infinite Enzymes, LLC (CEO)
  • Infinite Eversole Specialty Crop Services, LLC (Principal)


Thirty years experience in biology. Lipscomb Distinguished Professor of Agriculture at Arkansas State University. Previously, Associate Vice Chancellor for Research and Technology Transfer at ASU. Program Director in Molecular and Cellular Biosciences at the National Science Foundation. Leader in forming one of the world's foremost transgenic plant research groups at ProdiGene, a plant biotechnology start-up company. Director of the cell biology group for plant production of therapeutic proteins at Pioneer Hi-Bred International, a Fortune 500 Company. Internationally recognized for research program and associated expertise as evidenced by over 75 publications and patents as well as invitations to speak nationally and internationally.